{"topic":{"slug":"neurodegeneration","name":"Alzheimer's, Parkinson's & Neurodegeneration","domain":"medicine","description":"Anti-amyloid antibodies, plasma p-tau biomarkers, alpha-synuclein seed amplification, antisense therapies for ALS and emerging disease-modifying strategies.","keywords":["Alzheimer","neurodegeneration"],"paper_count":355,"latest_published":"2026-10-28","url":"https://space-kitty.com/topics/neurodegeneration","api_url":"https://space-kitty.com/api/v1/topics/neurodegeneration"},"dossier":null,"top_papers":[{"id":"doi:10.1056/nejmoa2212948","kind":"article","title":"Lecanemab in Early Alzheimer’s Disease","authors":["Christopher H. van Dyck","Chad J. Swanson","Paul S. S. Aisen","Randall John Bateman","Christopher Chen","Michelle Gee"],"author_count":19,"year":2022,"published":"2022-11-30","venue":"New England Journal of Medicine","cited_by":5673,"doi":"10.1056/nejmoa2212948","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1056/nejmoa2212948","archive_url":"https://space-kitty.com/papers/doi:10.1056/nejmoa2212948"},{"id":"doi:10.1038/s41392-024-01911-3","kind":"review","title":"Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies","authors":["Jifa Zhang","Yinglu Zhang","Jiaxing Wang","Yilin Xia","Jiaxian Zhang","Lei Chen"],"author_count":6,"year":2024,"published":"2024-08-23","venue":"Signal Transduction and Targeted Therapy","cited_by":1176,"doi":"10.1038/s41392-024-01911-3","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41392-024-01911-3","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41392-024-01911-3"},{"id":"doi:10.1001/jamaneurol.2023.5319","kind":"article","title":"Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology","authors":["Ashton NJ","Brum WS","Di Molfetta G","Benedet AL","Arslan B","Jonaitis E"],"author_count":27,"year":2024,"published":"2024-03-01","venue":"JAMA neurology","cited_by":770,"doi":"10.1001/jamaneurol.2023.5319","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1001/jamaneurol.2023.5319","archive_url":"https://space-kitty.com/papers/doi:10.1001/jamaneurol.2023.5319"},{"id":"doi:10.14283/jpad.2023.30","kind":"article","title":"Lecanemab: Appropriate Use Recommendations","authors":["Jeffrey L. Cummings","Liana G. Apostolova","Gil Dan Rabinovici","A Atri","Pau Aisen","Steven Mark Greenberg"],"author_count":11,"year":2023,"published":"2023-03-22","venue":"The Journal of Prevention of Alzheimer s Disease","cited_by":960,"doi":"10.14283/jpad.2023.30","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.14283/jpad.2023.30","archive_url":"https://space-kitty.com/papers/doi:10.14283/jpad.2023.30"},{"id":"doi:10.1186/s13195-021-00813-8","kind":"article","title":"A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody","authors":["Chad J. Swanson","Yong Zhang","Shobha Dhadda","Jinping Wang","June M. Kaplow","Robert Y. K. Lai"],"author_count":16,"year":2021,"published":"2021-04-17","venue":"Alzheimer s Research & Therapy","cited_by":844,"doi":"10.1186/s13195-021-00813-8","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1186/s13195-021-00813-8","archive_url":"https://space-kitty.com/papers/doi:10.1186/s13195-021-00813-8"},{"id":"doi:10.1038/s41591-024-02869-z","kind":"article","title":"Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests","authors":["Barthélemy NR","Salvadó G","Schindler SE","He Y","Janelidze S","Collij LE"],"author_count":21,"year":2024,"published":"2024-02-21","venue":"Nature medicine","cited_by":449,"doi":"10.1038/s41591-024-02869-z","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41591-024-02869-z","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41591-024-02869-z"},{"id":"doi:10.1007/s00401-021-02275-6","kind":"article","title":"Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology","authors":["Ashton NJ","Pascoal TA","Karikari TK","Benedet AL","Lantero-Rodriguez J","Brinkmalm G"],"author_count":15,"year":2021,"published":"2021-02-14","venue":"Acta neuropathologica","cited_by":615,"doi":"10.1007/s00401-021-02275-6","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1007/s00401-021-02275-6","archive_url":"https://space-kitty.com/papers/doi:10.1007/s00401-021-02275-6"},{"id":"doi:10.1038/s41591-022-01925-w","kind":"article","title":"Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease","authors":["Milà-Alomà M","Ashton NJ","Shekari M","Salvadó G","Ortiz-Romero P","Montoliu-Gaya L"],"author_count":21,"year":2022,"published":"2022-08-11","venue":"Nature medicine","cited_by":534,"doi":"10.1038/s41591-022-01925-w","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41591-022-01925-w","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41591-022-01925-w"},{"id":"doi:10.1007/s40259-023-00633-2","kind":"review","title":"Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease","authors":["Jeffrey L. Cummings","Amanda M. Leisgang Osse","Davis Cammann","Jayde Powell","Jingchun Chen"],"author_count":5,"year":2023,"published":"2023-11-13","venue":"BioDrugs","cited_by":377,"doi":"10.1007/s40259-023-00633-2","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1007/s40259-023-00633-2","archive_url":"https://space-kitty.com/papers/doi:10.1007/s40259-023-00633-2"},{"id":"doi:10.1007/s13311-022-01308-6","kind":"article","title":"Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease","authors":["Linda Söderberg","Malin Johannesson","Patrik Nygren","Hanna Laudon","Fredrik Eriksson","Gunilla Osswald"],"author_count":8,"year":2022,"published":"2022-10-17","venue":"Neurotherapeutics","cited_by":433,"doi":"10.1007/s13311-022-01308-6","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1007/s13311-022-01308-6","archive_url":"https://space-kitty.com/papers/doi:10.1007/s13311-022-01308-6"},{"id":"doi:10.1038/s41591-022-02074-w","kind":"article","title":"Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer's trial selection and disease monitoring","authors":["Ashton NJ","Janelidze S","Mattsson-Carlgren N","Binette AP","Strandberg O","Brum WS"],"author_count":23,"year":2022,"published":"2022-12-01","venue":"Nature medicine","cited_by":420,"doi":"10.1038/s41591-022-02074-w","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41591-022-02074-w","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41591-022-02074-w"},{"id":"doi:10.1186/s13195-022-01124-2","kind":"article","title":"Lecanemab in patients with early Alzheimer’s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study","authors":["Eric McDade","Jeffrey L. Cummings","Shobha Dhadda","Chad J. Swanson","Larisa Reyderman","Michio Kanekiyo"],"author_count":10,"year":2022,"published":"2022-12-21","venue":"Alzheimer s Research & Therapy","cited_by":306,"doi":"10.1186/s13195-022-01124-2","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1186/s13195-022-01124-2","archive_url":"https://space-kitty.com/papers/doi:10.1186/s13195-022-01124-2"},{"id":"doi:10.1002/alz.12748","kind":"article","title":"The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease","authors":["Michael S. Rafii","Reisa Anne Sperling","Michael Donohue","Jin Zhou","Claire Roberts","Michael C. Irizarry"],"author_count":17,"year":2022,"published":"2022-08-15","venue":"Alzheimer s & Dementia","cited_by":291,"doi":"10.1002/alz.12748","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1002/alz.12748","archive_url":"https://space-kitty.com/papers/doi:10.1002/alz.12748"},{"id":"doi:10.1186/s12929-023-00976-6","kind":"review","title":"Clinical trials of new drugs for Alzheimer disease: a 2020–2023 update","authors":["Li‐Kai Huang","Yi‐Chun Kuan","Ho-Wei Lin","Chaur‐Jong Hu"],"author_count":4,"year":2023,"published":"2023-10-02","venue":"Journal of Biomedical Science","cited_by":252,"doi":"10.1186/s12929-023-00976-6","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1186/s12929-023-00976-6","archive_url":"https://space-kitty.com/papers/doi:10.1186/s12929-023-00976-6"},{"id":"doi:10.1001/jamaneurol.2022.5272","kind":"article","title":"Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers","authors":["Mattsson-Carlgren N","Salvadó G","Ashton NJ","Tideman P","Stomrud E","Zetterberg H"],"author_count":16,"year":2023,"published":"2023-04-01","venue":"JAMA neurology","cited_by":295,"doi":"10.1001/jamaneurol.2022.5272","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1001/jamaneurol.2022.5272","archive_url":"https://space-kitty.com/papers/doi:10.1001/jamaneurol.2022.5272"}],"newest_papers":[{"id":"arxiv:2610.38172","kind":"preprint","title":"Data Amount Heterogeneity Improves Performance in Federated Learning for Neuroimaging","authors":["Paul Kurian","Tamoghna Chattopadhyay","Abhijith Shaji","Greg Ver Steeg","Paul M. Thompson","Jose Luis Ambite"],"author_count":6,"year":2026,"published":"2026-10-28","venue":null,"cited_by":null,"doi":null,"arxiv_id":"2610.38172","nct_id":null,"source_url":"https://arxiv.org/abs/2610.38172","archive_url":"https://space-kitty.com/papers/arxiv:2610.38172"},{"id":"doi:10.1038/s41467-026-78390-3","kind":"article","title":"Tau isoform mapping across tissues and biofluids reveals a signature distinguishing Alzheimer's disease from amyotrophic lateral sclerosis","authors":["Abu-Rumeileh S","Großkopf H","Guthknecht A","Mensch A","Osterloh D","Ratti A"],"author_count":27,"year":2026,"published":"2026-10-22","venue":"Nature communications","cited_by":0,"doi":"10.1038/s41467-026-78390-3","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41467-026-78390-3","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41467-026-78390-3"},{"id":"doi:10.1002/acn3.70562","kind":"article","title":"Associations Between Biomarkers of Alzheimer's Disease and Sleep in Cognitively Unimpaired Older Adults","authors":["Sauter C","Dorn H","Hellmann-Regen J","Bueno-Lopez A","van Ginneken V","Danker-Hopfe H"],"author_count":6,"year":2026,"published":"2026-10-21","venue":"Annals of clinical and translational neurology","cited_by":0,"doi":"10.1002/acn3.70562","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1002/acn3.70562","archive_url":"https://space-kitty.com/papers/doi:10.1002/acn3.70562"},{"id":"doi:10.1007/s00415-026-14194-1","kind":"article","title":"Serum p-tau181 and p-tau217 levels in adolescents and adults with 5q spinal muscular atrophy","authors":["Stapf CD","Uzelac Z","Iterbeke L","Guthknecht A","Barba L","Strube D"],"author_count":16,"year":2026,"published":"2026-10-21","venue":"Journal of neurology","cited_by":0,"doi":"10.1007/s00415-026-14194-1","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1007/s00415-026-14194-1","archive_url":"https://space-kitty.com/papers/doi:10.1007/s00415-026-14194-1"},{"id":"arxiv:2610.27150","kind":"preprint","title":"Cross-disorder Learning of Imaging-derived Joint Mophometric Markers in Alzheimer's and Parkinson's Diseases","authors":["Yuji Zhao","Boris Gutman"],"author_count":2,"year":2026,"published":"2026-10-19","venue":null,"cited_by":0,"doi":null,"arxiv_id":"2610.27150","nct_id":null,"source_url":"https://arxiv.org/abs/2610.27150","archive_url":"https://space-kitty.com/papers/arxiv:2610.27150"},{"id":"doi:10.1002/acn3.70560","kind":"article","title":"A Two-Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p-Tau217 Gray Zone","authors":["Parankusham H","Vanderlip C","Birkenbihl C","Krishna E","Ugboaja C","Budson AE"],"author_count":7,"year":2026,"published":"2026-10-19","venue":"Annals of clinical and translational neurology","cited_by":0,"doi":"10.1002/acn3.70560","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1002/acn3.70560","archive_url":"https://space-kitty.com/papers/doi:10.1002/acn3.70560"},{"id":"doi:10.1186/s40035-026-00583-z","kind":"article","title":"Exercise promotes lipophagy and mitigates cognitive impairment in Alzheimer's disease through downregulating microglial TMEM9","authors":["Zhang L","Li S","Ma X","Cheng S","Ye Z","Liu S"],"author_count":14,"year":2026,"published":"2026-10-19","venue":"Translational neurodegeneration","cited_by":0,"doi":"10.1186/s40035-026-00583-z","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1186/s40035-026-00583-z","archive_url":"https://space-kitty.com/papers/doi:10.1186/s40035-026-00583-z"},{"id":"doi:10.1016/j.tjpad.2026.100686","kind":"article","title":"Baseline MRI markers and clinical outcomes during anti-amyloid β therapy: A real-world study in a Japanese dementia center","authors":["Kujuro Y","Saito M","Maruko M","Kamiyama K","Nakano A","Qian E"],"author_count":15,"year":2026,"published":"2026-10-17","venue":"The journal of prevention of Alzheimer's disease","cited_by":0,"doi":"10.1016/j.tjpad.2026.100686","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/j.tjpad.2026.100686","archive_url":"https://space-kitty.com/papers/doi:10.1016/j.tjpad.2026.100686"},{"id":"doi:10.3390/neurolint18100195","kind":"review","title":"Fluid Biomarkers for the Antemortem Detection of Chronic Traumatic Encephalopathy: A Critical Review","authors":["Shatirishvili N"],"author_count":1,"year":2026,"published":"2026-10-17","venue":"Neurology international","cited_by":0,"doi":"10.3390/neurolint18100195","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.3390/neurolint18100195","archive_url":"https://space-kitty.com/papers/doi:10.3390/neurolint18100195"},{"id":"arxiv:2610.21660","kind":"preprint","title":"Transferable conditional brain charts link cortico-subcortical structure to Alzheimer's disease progression","authors":["Nitin Sharma","Sicheng Dai","Francesco A. Mallus","Atharva Kand","Marc Lemnitzer","Minh-Hieu Nguyen"],"author_count":32,"year":2026,"published":"2026-10-15","venue":null,"cited_by":0,"doi":null,"arxiv_id":"2610.21660","nct_id":null,"source_url":"https://arxiv.org/abs/2610.21660","archive_url":"https://space-kitty.com/papers/arxiv:2610.21660"}],"related_topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","api_url":"https://space-kitty.com/api/v1/topics/cancer-immunotherapy"},{"slug":"mrna-cancer-vaccines","name":"mRNA Therapeutics & Cancer Vaccines","api_url":"https://space-kitty.com/api/v1/topics/mrna-cancer-vaccines"},{"slug":"gene-editing-therapies","name":"CRISPR & Gene-Editing Therapies","api_url":"https://space-kitty.com/api/v1/topics/gene-editing-therapies"},{"slug":"gene-cell-therapy","name":"Gene & Cell Therapy","api_url":"https://space-kitty.com/api/v1/topics/gene-cell-therapy"},{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","api_url":"https://space-kitty.com/api/v1/topics/glp1-metabolic"},{"slug":"aging-longevity","name":"Biology of Aging & Longevity","api_url":"https://space-kitty.com/api/v1/topics/aging-longevity"},{"slug":"infectious-disease-amr","name":"Infectious Disease, Vaccines & Antimicrobial Resistance","api_url":"https://space-kitty.com/api/v1/topics/infectious-disease-amr"},{"slug":"ai-medicine","name":"AI in Clinical Medicine","api_url":"https://space-kitty.com/api/v1/topics/ai-medicine"},{"slug":"cardiovascular-innovation","name":"Cardiovascular Therapeutics","api_url":"https://space-kitty.com/api/v1/topics/cardiovascular-innovation"}],"premium":{"dossier":null,"research_pack":{"url":"https://space-kitty.com/api/v1/topics/neurodegeneration/pack","price_usd":"0.20"}},"more":"https://space-kitty.com/api/v1/topics/neurodegeneration/papers?sort=top&limit=100"}